Physician profile

Abby A Duclos

Obstetrics & Gynecology · Andover, MA

NPI 1841267390

$727.18

in general payments reported to CMS, 2019-2025

13 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$25.98

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Therapeuticsmd, INC. $187.07 2020-2021
Avion Pharmaceuticals $138.51 2019-2020
Exeltis, USA INC. $113.15 2020-2021
Abbvie INC. $80.54 2019-2024
Astellas Pharma US INC $39.63 2019-2020
Amag Pharmaceuticals, INC. $36.08 2019-2020
Hologic Sales and Service, LLC $30.61 2019-2022
Allergan, INC. $25.79 2019
Hologic INC $19.66 2021
Medicem INC. $16.50 2020
Merck Sharp & Dohme LLC $14.84 2019
Amgen INC. $13.62 2022
Pfizer INC. $11.18 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Abby A Duclos

$727.18

in general payments reported 2019-2025

Years
2019-2024
Top company
Therapeuticsmd, INC.

https://glasscript.com/doctor/129348/abby-a-duclos

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.